Tenax Therapeutics (TENX) Non-Current Debt: 2011-2013
Historic Non-Current Debt for Tenax Therapeutics (TENX) over the last 2 years, with Apr 2013 value amounting to $3.0 million.
- Tenax Therapeutics' Non-Current Debt rose 120.00% to $3.0 million in Q2 2013 from the same period last year, while for Apr 2013 it was $3.0 million, marking a year-over-year increase of 120.00%. This contributed to the annual value of $3.0 million for FY2013, which is 120.00% up from last year.
- Latest data reveals that Tenax Therapeutics reported Non-Current Debt of $3.0 million as of Q2 2013, which was up 15.79% from $2.6 million recorded in Q1 2013.
- Tenax Therapeutics' 5-year Non-Current Debt high stood at $6.2 million for Q4 2011, and its period low was $952,777 during Q1 2012.
- In the last 3 years, Tenax Therapeutics' Non-Current Debt had a median value of $2.6 million in 2013 and averaged $3.1 million.
- Per our database at Business Quant, Tenax Therapeutics' Non-Current Debt slumped by 69.51% in 2012 and then surged by 171.43% in 2013.
- Quarterly analysis of 3 years shows Tenax Therapeutics' Non-Current Debt stood at $6.2 million in 2011, then slumped by 64.75% to $2.2 million in 2012, then surged by 120.00% to $3.0 million in 2013.
- Its Non-Current Debt stands at $3.0 million for Q2 2013, versus $2.6 million for Q1 2013 and $2.2 million for Q4 2012.